Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

UCB (portfolio of Over-The-Counter medicine brands)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of Over-The-Counter drug brands in France, Benelux, Switzerland and Greece. The portfolio includes various medicine brands such as Carbolevure, Revitalose, Balsoclase and Toclase as well as different Over-The-Counter assets and patents for the distribution of drugs.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • Allée de la Recherche, 60
  • 1070 Brussels
  • Belgium

UCB (portfolio of Over-The-Counter medicine brands) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore UCB (portfolio of Over-The-Counter medicine brands)‘s full profile, request access.

Request full access to PitchBook

UCB (portfolio of Over-The-Counter medicine brands) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore UCB (portfolio of Over-The-Counter medicine brands)‘s full profile, request access.

Request full access to PitchBook